LifeVantage Announces Management Transition
Steven Fife Appointed Interim Chief Executive OfficerJustin Rose to Lead Combined Sales & Marketing TeamReiterates Fiscal 2021 GuidanceSALT LAKE CITY, […]
Superconductor Technologies Issues Letter to Stockholders
AUSTIN, Texas, Sept. 08, 2020 (GLOBE NEWSWIRE) — Superconductor Technologies Inc. (STI) (Nasdaq: SCON) issues the following Letter to StockholdersDear […]
Black Diamond Therapeutics Announces the Appointment of Rachel Humphrey, M.D., as Chief Medical Officer
CAMBRIDGE, Mass. and NEW YORK, Sept. 08, 2020 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology […]
Black Diamond Therapeutics Announces the Appointment of Rachel Humphrey, M.D., as Chief Medical Officer
CAMBRIDGE, Mass. and NEW YORK, Sept. 08, 2020 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology […]
Calavo Growers Announces Changes to its Board of Directors
SANTA PAULA, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) — Calavo Growers, Inc. (Nasdaq-GS: CVGW) (“Calavo” “Company”), a global avocado-industry leader […]
PDS Biotechnology to Participate in Upcoming Healthcare Investor Conferences
FLORHAM PARK, N.J., Sept. 08, 2020 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (“PDS Biotech” or the “Company”) (Nasdaq: PDSB), a […]
PetIQ, Inc. Provides Update on Wellness Center Reopening Plan
EAGLE, Idaho, Sept. 08, 2020 (GLOBE NEWSWIRE) — PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication […]
PDS Biotechnology to Participate in Upcoming Healthcare Investor Conferences
FLORHAM PARK, N.J., Sept. 08, 2020 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (“PDS Biotech” or the “Company”) (Nasdaq: PDSB), a […]
Prothena to Present at the 2020 Cantor Virtual Global Healthcare Conference on September 15
DUBLIN, Ireland, Sept. 08, 2020 (GLOBE NEWSWIRE) — Prothena Corporation plc (NASDAQ:PRTA), a clinical-stage company with expertise in protein dysregulation […]
Lexicon Pharmaceuticals Completes the Sale of XERMELO to TerSera Therapeutics
Lexicon Receives $160.4 Million at ClosingEligible for Up to $65 Million in Milestone Payments Plus Mid-Teens Royalties on Net Sales […]
